Journal
ENDOCRINE-RELATED CANCER
Volume 8, Issue 2, Pages 115-127Publisher
BIOSCIENTIFICA LTD
DOI: 10.1677/erc.0.0080115
Keywords
-
Categories
Funding
- NCI NIH HHS [CA78352, 2-T32CA09110, P50CA88843] Funding Source: Medline
Ask authors/readers for more resources
Like all cancers, breast cancer is considered to result in part from the accumulation of multiple genetic alterations leading to oncogene overexpression and tumor suppressor loss. More recently, the role of epigenetic change as a distinct and crucial mechanism to silence a variety of methylated tissue-specific and imprinted genes has emerged in many cancer types. This review will briefly discuss basic aspects of DNA methylation, recent advances in DNA methyltransferases, the role of altered chromatin organization and the concept of gene transcriptional regulation built on methylated CpGs, In particular, we discuss epigenetic regulation of certain critical tumor suppressor and growth regulatory genes implicated in breast cancer, and its relevance to breast cancer diagnosis, prognosis, progression and therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available